Proton Radiation Therapy for Pituitary Adenoma (PI01)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00798057
Recruitment Status :
(Due to slow enrollment and feasibility issues.)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 100 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patients treated at a radiation oncology clinic
Histologically proven pituitary adenoma.
Age 18 years or older.
Status post biopsy, gross total resection (from initial surgery for recurrent disease) or subtotal resection.
Good to moderate neurological function status
*Previous radiation that would compromise the ability to deliver the prescribed treatment.
Stieber V, Deguzman A, et al. Pituitary. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott Williams and Wilkins; 2004. p.839-859.
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases
Endocrine Gland Neoplasms
Neoplasms by Site
Central Nervous System Neoplasms
Nervous System Neoplasms